-
Something wrong with this record ?
PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications
C. Cammareri, F. Beltzung, M. Michal, L. Vanhersecke, JM. Coindre, V. Velasco, F. Le Loarer, B. Vergier, R. Perret
Language English Country Germany
Document type Journal Article
NLK
ProQuest Central
from 2003-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2011-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest)
from 2003-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 2003-01-01 to 1 year ago
- MeSH
- Antigens, Neoplasm MeSH
- Diagnosis, Differential MeSH
- DNA Helicases MeSH
- Adult MeSH
- Sarcoma, Ewing * diagnosis MeSH
- Fibrosarcoma * diagnosis MeSH
- Immunohistochemistry MeSH
- Nuclear Proteins MeSH
- Humans MeSH
- Melanoma * pathology MeSH
- Biomarkers, Tumor metabolism MeSH
- Skin Neoplasms * pathology MeSH
- Soft Tissue Neoplasms * diagnosis pathology MeSH
- Sarcoma * diagnosis pathology MeSH
- Transcription Factors MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
Preferentially expressed antigen in melanoma (PRAME) immunohistochemistry is currently used in pathology for the assessment of melanocytic neoplasms; however, knowledge of its expression patterns in soft tissue tumors is limited. PRAME immunohistochemistry (clone QR005) was assessed on whole tissue sections of 350 soft-tissue tumors and mimics (> 50 histotypes). PRAME immunoreactivity was evaluated as follows: 0 "negative" (0% positive cells); 1+ (1-25% positive cells); 2+ (26-50% positive cells); 3+ (51-75% positive cells), and 4+ "diffuse" (> 75% positive cells). PRAME was expressed in 111 lesions (0 benign, 6 intermediate malignancy, and 105 malignant), including fibrosarcomatous dermatofibrosarcoma protuberans (2/4, 0 diffuse), NTRK-rearranged spindle cell neoplasm (2/4, 0 diffuse), atypical fibroxanthoma (1/7, 0 diffuse), Kaposi sarcoma (1/5, 0 diffuse), myxoid liposarcoma (11/11, 9 diffuse), synovial sarcoma (11/11, 6 diffuse), intimal sarcoma (7/7, 5 diffuse), biphenotypic sinonasal sarcoma (3/3, 1 diffuse), angiosarcoma (10/15, 6 diffuse), malignant peripheral nerve sheath tumor (9/12, 4 diffuse), pleomorphic rhabdomyosarcoma (2/3, 2 diffuse), alveolar rhabdomyosarcoma (2/6, 0 diffuse), embryonal rhabdomyosarcoma (7/7, 4 diffuse), undifferentiated pleomorphic sarcoma (2/12, 1 diffuse), leiomyosarcoma (2/15, 1 diffuse), clear cell sarcoma of soft tissue (1/10, 0 diffuse), low-grade fibromyxoid sarcoma (1/5, 0 diffuse), Ewing sarcoma (2/10, 1 diffuse), CIC-rearranged sarcoma (8/8, 4 diffuse), BCOR-sarcoma (2/5, 1 diffuse), melanoma (20/20, 14 diffuse), and thoracic SMARCA4-deficient undifferentiated tumor (5/5, all diffuse). All tested cases of spindle cell lipoma, dedifferentiated/pleomorphic liposarcoma, dermatofibrosarcoma protuberans, solitary fibrous tumor, inflammatory myofibroblastic tumor, myxoinflammatory fibroblastic sarcoma, nodular fasciitis, myxofibrosarcoma, epithelioid hemangioendothelioma, atypical vascular lesion, hemangioma, lymphangioma, vascular malformation, papillary endothelial hyperplasia, GIST, gastrointestinal clear-cell sarcoma, malignant melanotic nerve sheath tumor, neurofibroma, schwannoma, granular cell tumor, alveolar soft part sarcoma, epithelioid sarcoma, extraskeletal myxoid chondrosarcoma, myoepithelioma, ossifying fibromyxoid tumor, angiomatoid fibrous histiocytoma, PEComa, dermatofibroma, pleomorphic dermal sarcoma, and chordoma were negative. PRAME shows imperfect specificity in soft-tissue pathology but may serve as a diagnostic adjunct in selected differential diagnoses that show contrasting expression patterns.
Bioptical Laboratory Ltd Plzen Czech Republic
Department of Biopathology Institut Bergonié Bordeaux France
Department of Pathology Bordeaux University Hospital UMR 1312 Inserm Bordeaux France
Department of Pathology Faculty of Medicine in Plzen Charles University Pilsen Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016653
- 003
- CZ-PrNML
- 005
- 20231026105639.0
- 007
- ta
- 008
- 231013s2023 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00428-023-03606-6 $2 doi
- 035 __
- $a (PubMed)37477762
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Cammareri, Chloé $u University of Bordeaux, Talence, France $u Department of Biopathology, Institut Bergonié, Bordeaux, France
- 245 10
- $a PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications / $c C. Cammareri, F. Beltzung, M. Michal, L. Vanhersecke, JM. Coindre, V. Velasco, F. Le Loarer, B. Vergier, R. Perret
- 520 9_
- $a Preferentially expressed antigen in melanoma (PRAME) immunohistochemistry is currently used in pathology for the assessment of melanocytic neoplasms; however, knowledge of its expression patterns in soft tissue tumors is limited. PRAME immunohistochemistry (clone QR005) was assessed on whole tissue sections of 350 soft-tissue tumors and mimics (> 50 histotypes). PRAME immunoreactivity was evaluated as follows: 0 "negative" (0% positive cells); 1+ (1-25% positive cells); 2+ (26-50% positive cells); 3+ (51-75% positive cells), and 4+ "diffuse" (> 75% positive cells). PRAME was expressed in 111 lesions (0 benign, 6 intermediate malignancy, and 105 malignant), including fibrosarcomatous dermatofibrosarcoma protuberans (2/4, 0 diffuse), NTRK-rearranged spindle cell neoplasm (2/4, 0 diffuse), atypical fibroxanthoma (1/7, 0 diffuse), Kaposi sarcoma (1/5, 0 diffuse), myxoid liposarcoma (11/11, 9 diffuse), synovial sarcoma (11/11, 6 diffuse), intimal sarcoma (7/7, 5 diffuse), biphenotypic sinonasal sarcoma (3/3, 1 diffuse), angiosarcoma (10/15, 6 diffuse), malignant peripheral nerve sheath tumor (9/12, 4 diffuse), pleomorphic rhabdomyosarcoma (2/3, 2 diffuse), alveolar rhabdomyosarcoma (2/6, 0 diffuse), embryonal rhabdomyosarcoma (7/7, 4 diffuse), undifferentiated pleomorphic sarcoma (2/12, 1 diffuse), leiomyosarcoma (2/15, 1 diffuse), clear cell sarcoma of soft tissue (1/10, 0 diffuse), low-grade fibromyxoid sarcoma (1/5, 0 diffuse), Ewing sarcoma (2/10, 1 diffuse), CIC-rearranged sarcoma (8/8, 4 diffuse), BCOR-sarcoma (2/5, 1 diffuse), melanoma (20/20, 14 diffuse), and thoracic SMARCA4-deficient undifferentiated tumor (5/5, all diffuse). All tested cases of spindle cell lipoma, dedifferentiated/pleomorphic liposarcoma, dermatofibrosarcoma protuberans, solitary fibrous tumor, inflammatory myofibroblastic tumor, myxoinflammatory fibroblastic sarcoma, nodular fasciitis, myxofibrosarcoma, epithelioid hemangioendothelioma, atypical vascular lesion, hemangioma, lymphangioma, vascular malformation, papillary endothelial hyperplasia, GIST, gastrointestinal clear-cell sarcoma, malignant melanotic nerve sheath tumor, neurofibroma, schwannoma, granular cell tumor, alveolar soft part sarcoma, epithelioid sarcoma, extraskeletal myxoid chondrosarcoma, myoepithelioma, ossifying fibromyxoid tumor, angiomatoid fibrous histiocytoma, PEComa, dermatofibroma, pleomorphic dermal sarcoma, and chordoma were negative. PRAME shows imperfect specificity in soft-tissue pathology but may serve as a diagnostic adjunct in selected differential diagnoses that show contrasting expression patterns.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a imunohistochemie $7 D007150
- 650 12
- $a sarkom $x diagnóza $x patologie $7 D012509
- 650 12
- $a nádory měkkých tkání $x diagnóza $x patologie $7 D012983
- 650 12
- $a Ewingův sarkom $x diagnóza $7 D012512
- 650 12
- $a nádory kůže $x patologie $7 D012878
- 650 _2
- $a transkripční faktory $7 D014157
- 650 12
- $a fibrosarkom $x diagnóza $7 D005354
- 650 12
- $a melanom $x patologie $7 D008545
- 650 _2
- $a diferenciální diagnóza $7 D003937
- 650 _2
- $a nádorové biomarkery $x metabolismus $7 D014408
- 650 _2
- $a DNA-helikasy $7 D004265
- 650 _2
- $a jaderné proteiny $7 D009687
- 650 _2
- $a antigeny nádorové $7 D000951
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Beltzung, Fanny $u Department of Pathology, Bordeaux University Hospital, UMR 1312 Inserm, Bordeaux, France
- 700 1_
- $a Michal, Michael $u Department of Pathology, Faculty of Medicine in Plzen, Charles University, Pilsen, Czech Republic $u Bioptical Laboratory Ltd., Plzen, Czech Republic
- 700 1_
- $a Vanhersecke, Lucile $u Department of Biopathology, Institut Bergonié, Bordeaux, France
- 700 1_
- $a Coindre, Jean-Michel $u University of Bordeaux, Talence, France $u Department of Biopathology, Institut Bergonié, Bordeaux, France
- 700 1_
- $a Velasco, Valérie $u Department of Biopathology, Institut Bergonié, Bordeaux, France
- 700 1_
- $a Le Loarer, François $u University of Bordeaux, Talence, France $u Department of Biopathology, Institut Bergonié, Bordeaux, France $u INSERM U1218, ACTION, Institut Bergonié, Bordeaux, France
- 700 1_
- $a Vergier, Béatrice $u University of Bordeaux, Talence, France $u Department of Pathology, Bordeaux University Hospital, UMR 1312 Inserm, Bordeaux, France
- 700 1_
- $a Perret, Raul $u Department of Biopathology, Institut Bergonié, Bordeaux, France. r.perret@bordeaux.unicancer.fr $u INSERM U1218, ACTION, Institut Bergonié, Bordeaux, France. r.perret@bordeaux.unicancer.fr $1 https://orcid.org/0000000326980249
- 773 0_
- $w MED00004660 $t Virchows Archiv : an international journal of pathology $x 1432-2307 $g Roč. 483, č. 2 (2023), s. 145-156
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37477762 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026105634 $b ABA008
- 999 __
- $a ok $b bmc $g 2000273 $s 1203015
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 483 $c 2 $d 145-156 $e 20230721 $i 1432-2307 $m Virchows Archiv $n Virchows Arch $x MED00004660
- LZP __
- $a Pubmed-20231013